387525002: Hydrochlorothiazide (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Diuretic (substance)\Thiazide diuretic (substance)\Hydrochlorothiazide (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Heterocyclic compound\Thiazide\Benzothiadiazine (substance)\Hydrochlorothiazide (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Hydrochlorothiazide (substance)	Is a	Thiazide diuretic (substance)	true	Inferred relationship	Some
Hydrochlorothiazide (substance)	Is a	Benzothiadiazine (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Olmesartin medoxomil + hydrochlorothiazide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Hydrochlorothiazide 12.5mg/telmisartan 80mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing fosinopril and hydrochlorothiazide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely fosinopril 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing precisely fosinopril 20 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing eprosartan and hydrochlorothiazide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Hydrochlorothiazide 25 mg and timolol maleate 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing precisely hydrochlorothiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing hydrochlorothiazide and moexipril hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 7.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 15 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing precisely hydrochlorothiazide 25 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing precisely bisoprolol 2.5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing hydrochlorothiazide and metoprolol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril 10 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing precisely hydrochlorothiazide 50 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Hydrochlorothiazide 12.5 mg and telmisartan 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing precisely amiloride hydrochloride 2.5 milligram and atenolol 50 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing amiloride and atenolol and hydrochlorothiazide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	3
Hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing bisoprolol and hydrochlorothiazide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing enalapril and hydrochlorothiazide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing hydrochlorothiazide and quinapril (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
médicament contenant olmésartan médoxomil et hydrochlorothiazide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 25 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing aliskiren and hydrochlorothiazide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing amlodipine and hydrochlorothiazide and valsartan (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	3
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram and valsartan 320 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing amlodipine and hydrochlorothiazide and olmesartan medoxomil	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing aliskiren and amlodipine and hydrochlorothiazide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Aliskiren (as aliskiren fumarate) 150 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some
Allergy to hydrochlorothiazide	Causative agent (attribute)	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Amiloride hydrochloride 2.5 mg and hydrochlorothiazide 25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely acebutolol 200 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely acebutolol 200 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely amiloride hydrochloride 2.5 milligram and atenolol 50 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely amiloride hydrochloride 2.5 milligram and atenolol 50 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely bisoprolol 10 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely bisoprolol 10 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Captopril 25 mg and hydrochlorothiazide 12.5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Captopril 25 mg and hydrochlorothiazide 25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely hydralazine hydrochloride 100 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely hydralazine hydrochloride 100 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Amiloride hydrochloride 5 mg and hydrochlorothiazide 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Amiloride hydrochloride 5 mg and hydrochlorothiazide 50 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Benazepril hydrochloride 5 mg and hydrochlorothiazide 6.25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Benazepril hydrochloride 5 mg and hydrochlorothiazide 6.25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Benazepril hydrochloride 20 mg and hydrochlorothiazide 12.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Benazepril hydrochloride 20 mg and hydrochlorothiazide 12.5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Benazepril hydrochloride 20 mg and hydrochlorothiazide 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Benazepril hydrochloride 20 mg and hydrochlorothiazide 25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely hydrochlorothiazide 25 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely hydrochlorothiazide 25 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely bisoprolol 2.5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely bisoprolol 2.5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1

Start Page 2 of 8 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461703016	Hydrochlorothiazide (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481615017	Hydrochlorothiazide	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1492148015	HCTZ	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
369561000195118	idroclorotiazide	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
816441000172116	hydrochlorothiazide	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
74661000195110	Hydrochlorothiazid	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module